PubMed page for Dr. Linnenbringer

  1. Christensen KD, Uhlmann WR, Roberts JR, Linnenbringer E, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Butson MB, Fasaye G, Hiraki S, Chen CA, Siebert U, Cook-Deegan R, Green RC for the REVEAL Study Group. A randomized controlled trial of disclosing genetic risk information for Alzheimer’s disease via telephone. Genetics in Medicine 2018: 20(1):132-141. PMID: 28726810
  2. Linnenbringer E, Geronimus AT, and Gehlert S. Black-White disparities in breast cancer subtype: the intersection of stress, biology, and genetics. AIMS Public Health 2017: 4(5):526-556. PMID: 29333472
  3. Christensen KD, Roberts JS, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Vernarelli JA, Bhatt DL, Linnenbringer E, Butson MB, Fasaye GA, Uhlmann WR, Hiraki S, Wang N, Cook-Deegan R, Green RC; REVEAL Study Group. Disclosing pleiotropic genetic risk assessment for Alzheimer disease: A randomized trial. Annals of Internal Medicine 2016: 164(3):155-163. PMID: 26810768
  4. Geronimus AT, Pearson JA, Linnenbringer E, Schulz AJ, Reyes AG, Epel E, Lin J, Blackburn E. Racial/ethnic and socioeconomic variation in telomere length in an urban community-based sample of broad adult age range. Journal of Health and Social Behavior 2015: 56(2):199-224. PMID: 25930147
  5. Christensen KD, Roberts JS, Zikmund-Fisher BJ, Kardia SLR, McBride CM, Linnenbringer E, Green RC. Associations between self-referral and health behavior responses to genetic risk information. Genome Medicine 2015: 7(1):10. PMID: 25642295
  6. Green RC, Christensen KD, Cupples LA, Relkin NR, Whitehouse PJ, Royal CDM, Obisesan TO, Cook Deegan R, Linnenbringer EL, Butson MB, Fasaye G, Levinson E, Roberts JS; REVEAL Study Group. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer’s disease. Alzheimer’s and Dementia 2015: 11(10):1222-30. PMID: 25499536
  7. Akinleye D, Roberts JS, Royal CDM, Linnenbringer E, Obisesan T, Fasaye G, Green RC. Differences between African American and white research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer’s disease.  Journal of Genetic Counseling 2011: 20(6):650-9. PMID: 21656311
  8. Linnenbringer E, Roberts JS, Hiraki S, Cupples A, Green RC. “I know what you told me, but this is what I think”: perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate. Genetics in Medicine 2010:  12(4):219-27. PMID: 20139767
  9. Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA; REVEAL Study Group. Disclosure of APOE genotype for risk of Alzheimer’s disease. New England Journal of Medicine 2009: 361(3):245-54. PMID: 19605829
  10. Cassidy MR, Roberts JS, Bird TD, Steinbart EJ, Cupples LA, Chen CA, Linnenbringer E, Green RC. Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer’s disease. Alzheimer’s and Dementia 2008: 4(6), 406-13. PMID: 19012865
  11. Christensen KD, Roberts JS, Royal CDM, Fasaye G, Obisesan T, Cupples LA, Whitehouse PJ, Butson MB, Linnenbringer E, Relkin NR, Farrer L, Cook-Deegan R, Green RC. Incorporating ethnicity into genetic risk assessment for Alzheimer’s disease: The REVEAL Study experience.  Genetics in Medicine 2008: 10(3), 207-214. PMID: 18344711
  12. Gooding HC, Linnenbringer E, Burack J, Roberts JS, Green RC, Biesecker BB. Genetic susceptibility testing for Alzheimer disease: Perceived threat and the search for information and control. Patient Education and Counseling 2006: 64(1-3), 259-67. PMID: 16860524
  13. LaRusse S, Roberts JS, Marteau TM, Katzen H, Linnenbringer E, Barber M, Whitehouse P, Quaide K, Green RC, Relkin N. Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer’s disease. Genetics in Medicine 2005: 7(1), 48-53. PMID: 15654228